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In Brief
Although HIV latency is currently thought
to arise when an infected cell transitions
from an activated to a resting state that is
non-permissive to viral expression, a
combination of modeling and synthetic
control of HIV Tat positive feedback
demonstrates that latency establishment
operates autonomously from cell state.
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Biological circuits can be controlled by two general
schemes: environmental sensing or autonomous
programs. For viruses such as HIV, the prevailing hy-
pothesis is that latent infection is controlled by cellular
state (i.e., environment), with latency simply an epi-
phenomenon of infected cells transitioning from an
activated to resting state. However, we find that HIV
expression persists despite the activated-to-resting
cellular transition. Mathematical modeling indicates
that HIV’s Tat positive-feedback circuitry enables
this persistence and strongly controls latency. To
overcome the inherent crosstalk between viral cir-
cuitry and cellular activation and to directly test this
hypothesis, we synthetically decouple viral depen-
dence on cellular environment fromviral transcription.
These circuits enable control of viral transcription
without cellular activation and show that Tat feedback
is sufficient to regulate latency independent of cellular
activation. Overall, synthetic reconstruction demon-
strates that a largely autonomous, viral-encoded pro-
gram underlies HIV latency—potentially explaining
why cell-targeted latency-reversing agents exhibit
incomplete penetrance.INTRODUCTION
Diverse biological systems, both natural and engineered, face
the challenge of surviving in variant and unpredictable environ-
mental conditions. One strategy is to sense surrounding condi-
tions and respond with environment-specific developmental
programs—there is a 1:1 correspondence between explicit sen-
sor-actuators and the extremely reduced form of this scheme in
which sensing and actuation are so tightly coupled that environ-
ment entirely actuates the program (Bull and Vogt, 1979). An
alternate strategy foregoes environmental sensing and actua-
tion, instead relying on autonomous programs (Knedler, 1947),
for example programs that intrinsically generate heterogeneity
in phenotypes and allow probabilistic ‘‘bet hedging’’ (Cohen,990 Cell 160, 990–1001, February 26, 2015 ª2015 Elsevier Inc.1966). For many systems, such as bacteriophage-l, it is unclear
whether environmental sensor-actuator schemes or autono-
mous programs are employed (Arkin et al., 1998; St-Pierre and
Endy, 2008; Zeng et al., 2010). The ensuing debates carry evolu-
tionary significance since sensor-actuator regulation can be
driven by crosstalk from coincidental signals and hence tied
to unrelated epiphenomena, whereas autonomous circuits are
invariably subjected to direct natural selection pressures. In
other words, if a phenotype is controlled by sensor-actuator
regulation, it can be an ‘‘epiphenomenon,’’ but if autonomously
regulated, the phenotype is invariably evolutionary hardwired
and directly selected for.
For HIV, the debate is clinically relevant; it remains unclear
whether the host-cell environment or autonomous viral circuitry
controls proviral latency, a long-lived viral dormancy state that
is the chief barrier to curative therapy (Richman et al., 2009;Wein-
berger and Weinberger, 2013). Upon infecting CD4+ T lympho-
cytes, HIV either actively replicates to rapidly produce progeny
virions or can enter a long-lived quiescent state (proviral latency),
from which it subsequently reactivates. These latently infected
cells form a viral reservoir, forcing patients to remain on lifelong
suppressive therapy. The prevailing view (Coffin and Swanstrom,
2013; Siliciano and Greene, 2011) holds that proviral latency re-
sults from HIV transcription being controlled by the host-cell
activation state (i.e., environment) since relaxation of activated
lymphocytes to a resting-memory state is correlated with
increased epigenetic silencing of the HIV promoter and increased
cytoplasmic sequestration of transcription factors that activate
HIV transcription (Pearson et al., 2008; Tyagi et al., 2010). In
this model, HIV infects activated T cells, which allow active viral
replication, and if these cells ‘‘relax’’ to resting-memory T cells,
which generally restrict HIV infection, viral latency ensues (Fig-
ure 1, left).
In contrast to the cellular control hypothesis, there is circum-
stantial evidence for an alternate model wherein latency is
controlled by viral gene-regulatory circuitry (Ho et al., 2013;
Jeeninga et al., 2008; Weinberger et al., 2005) without strict
dependence on cellular state (Figure 1, right). HIV encodes a
transcriptional master circuit that is driven by the HIV Tat pro-
tein, which amplifies expression from the viral promoter within
the HIV long terminal repeat (LTR), establishing positive feed-
back. Critically, minimal Tat positive-feedback circuits can
recapitulate latency, and stochastic fluctuations between a
AB
Figure 1. Two Models of HIV Latency Regu-
lation: Cell-State Control versus Autono-
mous Programming
(A) (Left) The prevailing hypothesis of HIV proviral
latency regulation. As CD4+ T cells relax from
an activated state (permissive to infection) to a
resting-memory state, the host-cell environment
silences HIV gene expression, restricting Tat
transactivation of the LTR. (Right) The alternate
hypothesis that HIV Tat positive feedback is robust
to changes of the host-cell environment and op-
erates autonomously despite changes in cell state.
The overlapping nature of cellular and viral regula-
tory circuits confounds testing between these hy-
potheses (i.e., the LTR actuates Tat feedback but
doubles as a sensor of the host-cell environment).
(B) If cell state and viral circuitry can be orthogo-
nalized (i.e., decoupled), the influence of cellular
state on viral latency can be analyzed via an
orthogonal 2D graphical correlation. (Left) If
cellular state dominates regulation of viral latency,
resting cells would inhibit viral circuitry while active
cells would induce viral gene expression, gener-
ating a strong correlation between cell state and
viral activity. (Right) If an autonomous latency cir-
cuit regulates latency, both latent and active viral
expression could be generated in either resting
cells or activated T cells, producing little correla-
tion between cell state and viral activity.transcriptionally on and off state in the Tat circuit are sufficient
to drive a phenotypic bifurcation between active and latent
expression, even in non-resting cells (Weinberger et al., 2005).
However, there is also evidence that cellular factors modulate
stochastic HIV expression to drive latency (Burnett et al.,
2009), confounding the hypothesis that latency is controlled
by an autonomous viral circuit.
Here, we test between the cell-state and autonomous-circuit
hypotheses for latency establishment. If latency is regulated by
host-cell state, viral expression should be tightly correlated
with cell state, whereas if the latency circuit is hardwired to func-
tion autonomously, then cellular state would be uncorrelated
with viral expression and tuning viral circuitry, independent of
cell state, would be sufficient to control HIV latency (Figure 1B).
Surprisingly, we find that viral expression is robust to cellular-
activation state in primary T cells, andmathematical models indi-
cate that this autonomy results from intrinsic properties of the
HIV Tat positive-feedback circuit. However, directly testing cir-
cuit autonomy to cell state is confounded by overlap between
cellular and viral networks—the same transcription factors that
alter cellular activation also activate the HIV LTR, triggering Tat
positive feedback (Karn, 2011). To circumvent this overlap, we
synthetically reconstruct the Tat circuit to decouple viral depen-
dence on the cellular environment from viral transcriptional regu-
lation (i.e., decouple viral sensing and actuation). The refactored
circuits chemically modulate viral expression independent of
cellular activation levels and show that Tat circuitry is sufficient
to overcome cell-driven silencing of HIV transcription during
cellular relaxation from active to resting. Overall, the results
argue that the Tat circuit is hardwired to establish latency largely
autonomous of cellular state.RESULTS
Donor-Derived Primary T Lymphocytes Maintain Robust
HIV Expression during Cellular Relaxation from
Activated to Resting
To test the prevailing ‘‘epiphenomenon’’ hypothesis of HIV
latency establishment, we aCD3/CD28 pre-activated donor-
derived primary human CD4+ T lymphocytes (to achieve a
CD25+CD69+ phenotype), infected them with full-length HIV-1
virus, and then removed activation stimuli, allowing infected cells
to relax to a resting (CD25CD69) state (Figure 2A). The virus
used (HIV-d2GFP) encodes a short-lived 2-hr half-life GFP
(d2GFP) reporter to enable rapid detection of viral transcriptional
silencing and is env mutated (i.e., single-replication round)
to avoid confounding the data with expansion of the infected
cell population. Infected cells were sampled periodically over
2 weeks for cellular activation status (as quantified by CD25
and CD69) alongside viral-GFP expression.
Surprisingly, viral expressionappears remarkably robustduring
the cellular transition from activated to resting (Figures 2B and
2C–2H). Despite drastic decline in cellular activation both in
CD25 (Figures 2D and 2G) and in CD69 (Figures 2C and 2F), viral
activity (quantified by GFP expression of productively infected
cells) remained relatively unchanged (Figures 2B, 2E, and 2H).
The resilience of viral gene expression despite cellular relaxation
is not due to differential relaxation of productively infected cells
compared to the overall population, as productively infected cells
relax at the same rate as the overall population (Figure S1).
Since human primary cells represent a mixed co-culture (i.e.,
infected and uninfected subsets of cells), which may obfuscate
the interpretation of results (Jordan et al., 2003), we alsoCell 160, 990–1001, February 26, 2015 ª2015 Elsevier Inc. 991
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Figure 2. HIV Expression Is Autonomous to Changes in Cellular State: Transitioning of Primary T Lymphocytes from Activated to Resting
Does Not Silence HIV Expression
(A) Schematic of activation, infection, and long-term observations of relaxing primary CD4+T cells with full-length HIV-d2GFP. Donor-derived primary cells were
activated with aCD3/CD28 beads in the presence of rIL-2 for 3 days, following which beads were removed and the cells were infected. At indicated time points,
cells were collected for flow-cytometry-based measurement of CD25/CD69 levels and GFP expression. Data shown (in B–E) are representative of duplicate
infections performed with cells from two donors.
(legend continued on next page)
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performed a refined version of the experiment by isolating HIV-
infected cells through FACS sorting and tracking this purified
population of infected lymphocytes as cells relaxed to resting
(Figure 2I). As before, even after 2 weeks of culture, 90% of
cells maintain high-level viral expression (Figure 2J) despite
cellular relaxation to resting (Figure S1). Collectively, these two
experiments show that, despite a 10-fold decline in CD4+ T cell
activation levels, the impact on viral gene expression is minimal,
suggesting that viral circuitry is largely autonomous to cellular
state.
Computational Analysis Predicts that Tat Feedback
Circuitry Can Autonomously Generate Active and Latent
Infection across a Broad Range of Cellular-Activation
States
To investigate how viral transcription remains robust despite cell-
state changes, we employ a simplified computational model of
HIV transcriptional regulation (Figure 3A) based on previous
studies (Weinberger et al., 2008). This model builds off the stan-
dard two-state model of transcription (Kepler and Elston, 2001;
Paulsson, 2004) and allows the LTR promoter to stochastically
toggle between a transcriptionally non-permissive state (LTROFF)
and a transcriptionally permissive state (LTRON) at rates koff and
kon, respectively. In the LTRON state, Tat protein can transactivate
the promoter, enhancing transcriptional elongation at a rate
ktransact. These parameters (koff, kon, and ktransact) have been quan-
tified by single-cell analysis (Dar et al., 2012; Singh et al., 2010;
Weinberger et al., 2008), and measurements at thousands of
HIV integration sites across the human genome show kon to be
the predominant parameter that alters LTR activity in the regime
required for latency (Dar et al., 2012), i.e., the weak expression
regime. Potent cell-state activators, such as tumor necrosis fac-
tor a (TNFa), which acts through the same pathway as aCD3/
CD28 activation, maximally stimulate LTR activity by increasing
kon by 1.5- to 2-fold (Dar et al., 2012, 2014; Jordan et al., 2001).
To determine whether relaxation of activated T cells (i.e., de-
creases in kon) can drive LTR-Tat circuit shutoff and latency,
we simulated infection of activated T cells and examined how
tuning kon alters the fraction of trajectories in the ON state;
i.e., initial conditions were LTRON = 1, and all other molecular
species = 0 (see Table S1), thereby allowing efficient Tat turn-
on in activated cells with subsequent stochastic circuit shutoff.
The simplified model recapitulates previous results showing a
phenotypic bifurcation in Tat levels (Weinberger et al., 2005),
with a fraction of trajectories remaining ON and a fraction turning
OFF (Figure 3B) for any given kon across a broad range of values(B) Flow cytometry time course of CD25 and GFP levels taken on indicated days p
(C–E) Histograms of cellular activation levels CD25 (C) and CD69 (D) of the entire
GFP+ gate in B) over the course of 13 days post infection (17 days post cellular
(F-H) Cellular activation levels and GFP levels for all replicates over the experimen
and represents the geometric mean of the distribution as seen in C–E. Solid lin
(maximal); GFP normalized to day 4 when viral activity is first observed.
(I) Schematic of FACS-based isolation of productively infected cells. 4 days pos
(J) Histograms of isolated GFP+ cells over time. Numbers indicate the proportion o
black bar). Day 4: Gray histogram shows the infected population prior to FACS-b
gray histogram that is GFP+ at day 4). Histogram in green (for days 4, 9, and 13) sho
data shown above are from donor 1.
See Figure S1 for results from donor 2 and CD25 expression decline during the(Figure 3C). Indeed, for LTR activities within three orders of
magnitude (Figure S2), any trajectory can maintain either an
ON or OFF state purely by altering the level of Tat without a
change in basal LTR activity. Thus, the model predicts that, at
a given cellular-activation state (kon value), circuit activity could
be toggled ON and OFF simply by supplying Tat alone (e.g., in
trans) without activating the LTR or changing the cellular-activa-
tion state (e.g., via TNFa). Moreover, the ON fraction can also be
altered by changing Tat abundance—and hence feedback
strength—through Tat half-life modulation (Figure S2).
Next, we directly examined how decreases in kon influenced
circuit activity. For all 2-fold decreases in kon (over three orders
ofmagnitude), there is >90% robustness in the percentage of tra-
jectories in the ON state (Figure 3D). 2-fold decreases in LTR ac-
tivity were examined because removal of cell-state activators
(e.g., TNFa), result in 1.5- to 2-fold reductions in LTR activity
(Dar et al., 2012; Jordan et al., 2001), but comparable circuit
robustness was observed for all 4-fold and even 1-Log
reductions in kon (Figure S2). In fact, the simplified nature of the
computational model allows derivation of an analytical ‘‘closed-
form’’ solution for the fraction of ON trajectories as a function
of time for all parameters (see Extended Experimental Proce-
dures), thereby enabling phase-plane analysis of the ON fraction
as a function of kon and ktransact (Figure S2). This phase-plane
sensitivity analysis demonstrates that—throughout the physio-
logical parameter regime of ktransact > kon (Dar et al., 2012; Molle
et al., 2007)—even if an infected cell lives far longer than the
in vivo lifetime of 40 hr (Perelson et al., 1996), kon modulation
cannot substantially alter the ON fraction. To be completely
sure that these results were not a peculiarity of the specificmodel
used, we also examined an alternate positive-feedback model
topology (Weinberger et al., 2005)—which encodes substantially
more molecular detail but is experimentally validated—and we
observed similar circuit robustness to decreases in kon (Fig-
ure S2). Analytical solution shows that this robustness results
from the strong positive feedback (ktransact > kon), since changes
in kon produce small corrections. Notably, despite the circuit’s
robustness to cellular relaxation (kon decreases), high values of
kondogenerate less-frequent latency in both the simplifiedmodel
(Figure 3C) and the complex models (Weinberger et al., 2005). In
fact, the analytical solution quantifies how increases in kon (e.g.,
via NFkB stimulation) reactivate the circuit from a latent state
(Equation 12, Extended Experimental Procedures).
Overall, the results demonstrate robustness of LTR-Tat circuit
activity to cellular relaxation (i.e., reductions in kon), consistent
with primary cell observations (Figure 2), but, critically, alsoost infection. Dotted line indicates gating for productively infected cells (GFP+).
population alongside GFP expression from productively infected cells (cells in
activation).
tal time course. Each dot indicates the time point from an independent infection
e connects the mean of the replicates. CD25 and CD69 normalized to day 0
t infection, GFP+ cells were isolated and cultured (repeated for two donors).
f cells that fall within the gate for positive GFP expression (marked by horizontal
ased separation. Viral titer was calibrated to achieve 10% infection (fraction of
ws the GFP expression in the isolated productively infected cells (post sort). All
experiment.
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Figure 3. Computational Analysis Predicts that Tat Positive-Feedback Circuitry Underlays HIV Autonomy to Cell State
(A) Schematic of a simplified model of the Tat-feedback circuit. The LTR promoter can toggle between a state where transcriptional elongation is stalled (LTROFF)
and a state where elongation proceeds (LTRON) at rates koff and kon, respectively, (Dar et al., 2012; Singh et al., 2010, 2012) and Tat protein transactivates
the promoter by enhancing transcriptional elongation at a rate ktransact (Razooky and Weinberger, 2011). Tat protein and mRNA decay at rates dm and dp,
respectively.
(B) Stochastic Monte-Carlo simulations (‘‘Gillespie’’ algorithm) of Tat protein levels (in arbitrary number of molecules) in individual cells over time (from reaction
scheme in A). Each trajectory represents an individual cell; 100 single-cell trajectories shown (initial conditions for all species equal zero at time t = 0, except
LTRON = 1); see Extended Experimental Procedures for reaction rates.
(C) Bee-Swarm plots of circuit activity (Tat levels at t = 200) over a range of kon values. Each data point represents a single-cell trajectory, (200 trajectories shown
per kon value). The width of the collection of cells (dots) having zero level of Tat (bottom of each kon value simulated) shows that high values of kon do generate less
frequent latency (smaller number of dots). Compare, for example, the spread of red dots (kon = 10
3) and black dots (kon = 10
2) at 0.
(legend continued on next page)
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show sensitivity of latency to changes in Tat abundance or
changes in Tat half-life. Below, we experimentally test these
computational predictions: (1) that LTR-Tat circuit activity be-
tween latent and active can be toggled by Tat levels alone (i.e.,
independent of cellular-activation state), (2) that Tat is more
effective at activation from latency than cell-state modifiers,
and (3) that cellular relaxation to resting does not silence Tat pos-
itive-feedback circuitry.
A Minimal Synthetic Circuit Shows that Viral
Reactivation from Latency Can Be Toggled
Independent of Cellular Activation
To test whether HIV gene-regulatory circuitry can control proviral
latency without changes in cellular-activation state, we devel-
oped synthetic circuits in which viral expression could be
toggled independent of cell state. The synthetic circuits are
based upon a minimal model of the HIV latency circuit and
encode a transcriptional positive-feedback loop in which HIV
Tat amplifies expression from the HIV LTR promoter (Jordan
et al., 2001; Weinberger et al., 2005). Theminimal LTR-Tat circuit
is sufficient to recapitulate latent gene expression; stimulation
with cell-state modifiers reactivates proviral expression from a
non-expressive ‘‘OFF’’ state to a high-level ‘‘ON’’ state.
The minimalist synthetic toggle circuit encodes Tat fused to a
controllable proteolysis tag, FKBP (Banaszynski et al., 2006), un-
der the control of the HIV LTR (Figure 4A). FKBP degradation is
reversibly inhibited by a small molecule, Shield-1, allowing Tat
half-life to be rapidly tuned. The Tat-FKBP fusion was also
tagged with a photo-switchable fluorescent protein, Dendra-2
(Gurskaya et al., 2006), which allows for light-based pulse-chase
experiments (Zhang et al., 2007) to measure Tat half-life destabi-
lization in single cells (Figure S3). In this minimal LTR-Tat-
Dendra-FKBP viral vector, Tat half-life is reduced to 2.5 hr in
the absence of Shield-1 (a 3.3-fold reduction from its native
half-life) but returns to its native 8 hr half-life (Weinberger and
Shenk, 2007) in the presence of 1 mM Shield-1.
Simulations predict that changes in Tat half-life should be suf-
ficient to toggle HIV positive feedback between ON and OFF at a
majority of viral integration sites (Figure S2). As predicted,
altering the Tat half-life by addition or removal of Shield-1 was
sufficient to toggle between latent and active expression across
an array of integration sites (Figure 4B). The observed reactiva-
tion is not due to pleiotropic effects of Shield-1 since Tat-Dendra
fusion proteins lacking FKBP are insensitive to Shield-1 (Fig-
ure S3). Moreover, the increased expression levels cannot
simply be due to an increase in the half-life of the reporter (Den-
dra-2), as the expression increases are substantially greater than
the 3.3-fold increase in half-life caused by Shield-1 (Figure S3).
To be completely sure that reporter half-life changeswere not ac-
counting for the increased expression, we also decoupled the
fluorescent reporter half-life from the Tat half-life by creating a
polycistronic system in which the reporter protein and Tat are
transcriptionally fused, but not translationally fused (Figure S4).(D) Fold change in percentage of trajectories in ON state for 2-fold reductions in k
over three orders of magnitude. Phase-plane analysis (i.e., sensitivity analysis) from
physiological parameter regime (ktransact > kon).
See also Figure S2 and Table S1.The polycistronic system corroborates the finding that Tat posi-
tive feedback is sufficient to control viral switching from an inex-
pressiveOFF to expressiveONstate (FigureS4). Thus, in both the
translational and transcriptional fusions, Shield-1 toggles the cir-
cuit between ON and OFF. These data indicate that tuning Tat
positive feedback is sufficient to toggle HIV gene expression be-
tween a quiescent state and an actively expressing state and that
viral expression can be activated without activating cell state.
Tat Induction Alone Is More Efficient Than Cell-State
Activation for Reactivating Latent Clones
One caveat of using tunable proteolysis systems to toggle the
Tat circuit is that a minimal level of Tat protein must be present
in the off state—i.e., modulating protein half-life when protein
concentration is zero has no effect. Thus, the Tat-FKBP
approach is unable to test whether Tat can reactivate latent cells
that are fully silenced. To circumvent this obstacle and test
whether Tat induction is sufficient to reactivate completely
silenced LTRs, we developed a set of open-loop circuits, based
on the Tet-On system (Gossen andBujard, 1992), that induce Tat
expression de novo. These systems allow tight induction of Tat
expression upon Doxycycline (Dox) addition. To examine the ef-
fects of Tat induction on HIV gene expression, these circuits
were incorporated into cells that encoded an HIV LTR promoter
driving themCherry fluorescent reporter (Figure 4C), and a library
containing 33 distinct LTR clonal integration sites was examined.
The Tet-On circuits show that Tat by itself is sufficient to toggle
cells between OFF and ON and to control the mean levels of LTR
expression despite the large clonal variation (Figure 4D). Impor-
tantly, a number of clones (clones 1–3) exhibit no detectable LTR
expression in the absence of Tat induction—the conventional
threshold for latency. But, inducing Tat expression is sufficient
to fully reactivate these clones without the need for any cell-state
activation signals.
Next, to test the effects of cell-state activation, Tet-inducible
isoclonal populations were exposed to an array of standard
cell-state modifiers. These agents are potent activators of T lym-
phocytes (Pazin et al., 1996) and also of the LTR (Jordan et al.,
2001; Karn, 2011). For example, TNFa strongly activates T cell
state by stimulating nuclear localization of the nuclear factor of
activated T cells (NFAT) and by stimulating recruitment of the
p50-RelA heterodimer to promoters containing NF-kB-binding
sites (Karin and Lin, 2002). If cell-state activation were the domi-
nant factor controlling latency, then cell-state modulators should
strongly reactivate latent mCherry expression in the Tet-induc-
ible system. Strikingly, cell-state activation alone only slightly in-
creases LTR expression and the percentage of cells in the ON
state, across the library of 33 distinct integration sites (Figure 4E).
In contrast, induction of Tat (by Dox) drastically increases the
percentage of cells in the ON state to near 100% (Figure 4E).
This dramatic difference between direct Tat induction versus
cell-state modifiers demonstrates that ktransact > kon for the HIV
circuitry and indicates that Tat-mediated transactivation is faron. Circuit activity (%ON) is largely robust to reductions in LTR activity (i.e., kon)
a closed-form analytical solution shows that this behavior is robust across the
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Figure 4. Synthetic Tuning of Tat Circuit Ac-
tivity Is Sufficient to Control Latent HIV
Expression in the Absence of Cellular Acti-
vation
(A) Schematic of the minimal LTR-Tat-Dendra-
FKBP lentiviral circuit. In the absence of Shield-1,
the Tat-Dendra-FKBP fusion protein is rapidly
degraded, diminishing positive feedback. When
Shield-1 is added, FKBP-mediated proteolysis is
blocked, allowing Tat levels to increase and
enabling strong Tat positive feedback.
(B) Flow cytometry histograms of eight isoclonal
populations of Jurkat cells infected with LTR-Tat-
Dendra-FKBP in the absence of Shield-1 (light
gray histograms) or the presence of 1 mM Shield-1
(dark gray histograms). Gating of the Dendra-
positive region (right of black-dashed line) was set
relative to naive, un-transduced Jurkat cells. See
also Figures S3 and S4.
(C) Schematic of the synthetic system (left) and
flow cytometry data of the LTR expression in cells
transduced with the synthetic circuit (right). The
synthetic circuit is composed of an rTta activator
constitutively expressed from an SFFV promoter.
In the presence of Dox, rTta protein activates
the Tet-On promoter to drive expression of the
Tat-Dendra fusion protein. Tat transactivates
expression from the HIV-1 LTR promoter, and LTR
activity is measured by mCherry expression.
(D) LTR mCherry expression is shown for 11
representative isoclonal populations in the
absence of Dox (light gray histograms) or after
Dox addition (dark gray histograms).
(E) Flow cytometry analysis of a library contain-
ing 33 distinct LTR clonal integration sites sub-
jected to Dox and a panel of standard cell-
state modifiers: TNFa, phorbol myristate acetate
(PMA), PMA-ionomycin, suberanilohydroxamic
acid (SAHA/vorinostat), trichostatin A (TSA), or
prostratin.
Error bars show SD.stronger an effect than the switching of the LTR to an ON state
through cell-state modifications. Collectively, these data (Fig-
ure 4E) indicate that activating cell-state alone is not sufficient
to control HIV transcription. These results in no way exclude a
role for cellular state in HIV reactivation in vivo. Rather, the suffi-
ciency of Tat-mediated viral reactivation without cell-state modi-
fication emphasizes the autonomy of the HIV Tat circuit.
Refactoring of Full-Length Replicating HIV Indicates
that Latency Establishment and Reactivation Depend on
Viral-Circuit Activity and Are Largely Independent of
Cellular Activation
We next tested whether viral circuitry could control latency in full-
length replicating virus. First,wedevelopedadecoupled system in996 Cell 160, 990–1001, February 26, 2015 ª2015 Elsevier Inc.which Tat expression is controlled by the
cells (via Tet-On) completely indepen-
dently of the virus. The engineered cells,
termed ‘‘inducible Tat cells,’’ contain a sta-
ble integrated Tet-inducible Tat-Dendracassette and provide in trans complementation of Tat for a reengi-
neered Tat-deleted full-length virus, the DTat-Cherry virus. The
DTat-Cherry virus was constructed from a full-length HIV molecu-
lar clonecontainingaTatdeletion (Huangetal., 1994) andencodes
an mCherry fluorescent reporter within nef (Figure 5A). In these
inducible Tat cells, viral gene expression can be toggled on even
if initial Tat levels are zero and virus replicates only in the presence
of Dox and, as with conventional strains, virus is inhibited by HIV
protease inhibitors (Figure S5). Inducing Tat expression in these
cells during infection with DTat-Cherry virus shows a 400% in-
crease in active infection compared to non-induced DTat
Cherry-infected cells (Figure 5B), indicating that absence of Dox
drives the virus to enter latency in agreement with findings that
Tat protein can inhibit establishment of latency (Donahue et al.,
AC
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B Figure 5. Tat Feedback Circuitry Is Suffi-
cient to Control Active-versus-Latent Infec-
tion in Full-Length Viruses
(A) Schematic of experiment: A Jurkat cell line in
which Tat-Dendra is expressed only in the pres-
ence of Dox, ‘‘inducible Tat cells,’’ was infected
with full-length DTat-Cherry virus in the presence
(+) or absence () of Dox to score for latency and
to score reactivation. Dox infections were sub-
sequently induced by Dox.
(B) Percent of cells actively infected (actively ex-
pressing mCherry) 2 days post infection. 30% of
cells were actively infected in the presence of Dox
(blue), while only 7% of cells were actively infected
in the absence of Dox (red). Upon subsequent Dox
incubation of the Dox infection, 28% of cells
reactivated to active infection (purple), indicating
that virtually all latent cells can be reactivated with
Tat induction.
(C) Experiment schematic: CEM T cells were
infected with either full-length Tat-FKBP virus
or control virus in the presence or absence of
Shield-1.
(D) Percent of cells actively infected (actively
expressing Dendra) 2 days post infection. For
the control virus infection, 25.8% ± 1.0% of cells
exhibit active infection in the presence of 1 mM
Shield-1 (blue), while 26.0% ± 2.7% exhibit
active infection in the absence of Shield-1 (red).
For the Tat-FKBP virus infection, 17.5% ± 1.7%
of cells exhibit active infection in the presence
of 1 mM Shield-1 (blue), while 7.5% ± 1.0% of
cells exhibit active infection in the absence
of Shield-1 (red). Infections were performed in
triplicate. Error bars = 1 SD. Control virus
infection and Tat-FKBP virus infection are inde-
pendent experiments (infection titers of the two
are different).
(E) Comparison of viral circuit versus cell-state
activation by quantifying the percentage of delta-
Tat virus infections that enter the active state.
In the absence of TNFa or Dox, 2% of cells
generate active HIV replication. Dox addition
increases active infections to 13%, while
TNFa generates 4% actively infected cells. The same can be seen by plotting Tat expression level (Dendra). Again, TNFa by itself leaves expression
level unchanged over that in absence of treatment. Addition of Dox leads to >2-fold increase in expression.
Also see Figure S5 for the experiment repeated with Dox and a panel of cell-state modifiers.2012). Strikingly, subsequent induction of Tat expression by Dox
fully reactivates latent virus to levels observed in the initial infection
with Dox (Figure 5B). Further, Dox was far more effective in reacti-
vating latent virus than any of the standard cell-state modifiers:
TNFa, PMA, PMA-ionomycin, SAHA/vorinostat, TSA, or prostratin
(FigureS5).Hence, latentprovirus canbe reactivatedbyTat induc-
tion alone,without altering cellular-activation state, demonstrating
that Tat is sufficient to control latent reactivation in full-length HIV.
Next, to check whether Tat induction in cis (i.e., within the
positive-feedback loop) could also control latency in full-length
virus, we reengineered the DTat-Cherry virus to encode either
the Tat-Dendra-FKBP cassette, referred to as ‘‘Tat-FKBP virus’’
(Figure 5C), or a control Tat-Dendra cassette, referred to as ‘‘Tat-
Dendra control virus,’’ or simply ‘‘control virus’’ (Figure S5). As
previously established in these nef-reporter viruses, actively
replicating infections express reporter, while latent infectionsare quantified by absence of reporter expression (Jordan et al.,
2003; Pearson et al., 2008). In control HIV infections, Shield-1
has no measureable effect on active-versus-latent infection (Fig-
ure 5D). In striking contrast, in Tat-FKBP virus infections, modu-
lating Tat positive-feedback strength with Shield-1 alters the
percentage of actively infected cells by 141%, i.e., >2-fold (Fig-
ure 5D). The reduction in actively infected cells is not due to
reduced input virus since equivalent titers of virus (i.e., MOIs)
were used in the presence and absence of Shield-1 and the
lack of measureable difference in infection in control HIV infec-
tions indicates that Shield-1 is not inducing abortive infections
and that hypothetical pleiotropic effects of Shield-1 cannot
explain the difference in active-versus-latent infection. Overall,
these results show thatmodulating viral feedback strength is suf-
ficient to control the establishment of active-versus-latent infec-
tion in full-length replicating virus.Cell 160, 990–1001, February 26, 2015 ª2015 Elsevier Inc. 997
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Figure 6. Tat Feedback Circuitry Is Suffi-
cient to Autonomously Regulate Viral
Expression during the Activated-to-Resting
Transition in Primary T Cells
(A) Experiment schematic: Donor-derived primary
CD4+ T lymphocytes were activated and infected
with LTR-Tat-Dendra-FKBP in either the presence
of Shield-1 (blue, wild-type feedback) or without
Shield (red, attenuated feedback), and cells were
allowed to relax back to resting (as measured
by CD25 surface expression) in the presence/
absence of Shield-1 (i.e., under wild-type/attenu-
ated feedback).
(B) Flow cytometry analysis of viral expression
(Dendra fluorescence) in primary CD4+ T lympho-
cytes during transition from activated to resting in
absence of Shield-1 (attenuated feedback; top) or
presence of Shield-1 (wild-type feedback; bot-
tom); activated are lymphocytes shown as opaque
histograms, and resting lymphocytes are shown
as translucent histograms.
(C) Plot of the fold change in the number of active
infections for varying cellular state (fold change cell
activation as measured by CD25 surface expres-
sion; see also Figure S6). If feedback strength is
wild-type (blue data points; blue trend line), the fold
change in viral activity is uncorrelated with
changing cell state. In the presence of attenuated
feedback, the percentage of active infections is
dependent on cell state. Each data point is
normalized against the percent of active infections
in the lowest cell-state activation data point.Tat Induction Is >300% More Effective Than Cellular
Activation for Reactivating Full-Length Latent HIV
To directly compare the effects of tuning viral circuitry to altering
cellular-activation state, inducible Tet-Tat-Dendra cells were in-
fectedwithDTat virus in the presence of Dox or TNFa (Figure 5E).
Modifying cellular activity with TNFa, in the absence of Tat induc-
tion, leads to a 1.5-fold change in the percentage of active infec-
tions (from 2% to 4% active infection), whereas Tat induction
drastically increases, by >300%, the proportion of infections
that are active (Figure 5E). Similar results were seen in reactivat-
ing latent cells post infection (Figure S5): inducible Tet-Tat-Den-
dra cells were infected with DTat virus and 3 days post infection
were treated with either Dox or standard cell-state modulators
(as well as combination of the two). Tat induction through Dox
was significantly more effective at reactivation than the cell-state
modifiers. Thus, as seen with the minimal-synthetic circuits (Fig-
ure 4), perturbing viral circuitry provides substantially more
potent reactivation of latency than targeting cell state alone.
Tat Circuitry Is Sufficient to Autonomously Regulate
Viral Expression during the Activated-to-Resting
Transition in Human Primary T Lymphocytes
As a final test, we directly examined the model prediction that
Tat circuitry alone is sufficient to explain the resilience of HIV
transcription to cellular silencing during cellular relaxation from
activated to resting (Figure 3D). Activated primary CD4+ T cells
were transduced with LTR-Tat-Dendra-FKBP virus and allowed
to relax from an active to a resting-memory state while Tat pos-998 Cell 160, 990–1001, February 26, 2015 ª2015 Elsevier Inc.itive-feedback strength was either maintained or attenuated by
removing Shield-1 (Figure 6A).
When Tat positive feedback is attenuated (by absence of
Shield-1) as lymphocytes relax from activated to memory, signif-
icant silencing of HIV gene expression occurs (Figure 6B, red his-
tograms). However, when Tat positive-feedback strength is
maintained at wild-type levels (via Shield-1 addition), only a slight
shift in HIV gene expression occurs as lymphocytes transition
from active to memory (Figure 6B, blue histograms). Quantifying
the relaxation of cellular activation alongside viral latency reveals
a remarkable relationship: if Tat feedback is attenuated, the
cellular-activation state tightly controls entry to latency by signif-
icantly reducing the percentage of cells in active infection (Fig-
ure 6C, red); however, when Tat feedback is active (the case in
Figure 2), the cellular activation state has no bearing on entrance
into latency as the percentage of cells in active infection remains
constant (Figure 6C, blue)—i.e., the intact feedback circuit al-
lows viral gene expression to act completely independent of
cellular-activation state. Thus, active Tat feedback appears to
buffer HIV from global transcriptional silencing as primary lym-
phocytes transition from active to resting memory.
DISCUSSION
Beginning with observations that HIV gene expression is
largely autonomous to cellular relaxation (Figure 2), computa-
tionally guided synthetic reconstruction revealed Tat positive
feedback as the core mechanism underlying viral autonomy
(Figures 3–5). Strikingly, Tat feedback alone is sufficient to
overcome cell-driven silencing of HIV transcription during
cellular relaxation from active to resting in primary T cells (Fig-
ure 6). These findings are consistent with patient-cell latent-re-
activation experiments showing that direct addition of Tat
activates viral expression and reverses latency in resting
CD4+ T cells without requiring cellular activation (Lassen
et al., 2006; Lin et al., 2003). Thus, in patient cells, Tat-medi-
ated positive feedback also appears to regulate latency inde-
pendent of cell state.
The data herein cannot discount one variant of the cell-state
hypothesis which proposes that latency is established when
HIV infects relaxing cells which are at an activation level just
above a first threshold required for HIV infection and integration
but below a second threshold required to sustain active Tat
expression and viral replication. However, there are difficulties
with this hypothesis. While the presence of two thresholds is
plausible, the second (Tat activation) threshold being higher
than the first (infection) threshold is not consistent with existing
data. For example, although global activation of primary CD4+
T cells is required for efficient infection, HIV can be reactivated
from latency in primary cells without globally activating the cells
(Xing et al., 2012). Similarly, the reactivation of HIV in resting
T cells using Tat protein (Lassen et al., 2006; Lin et al., 2003) in-
dicates that extremely low levels of cellular activation (i.e., in
resting/quiescent cells) are still amenable to robust viral ex-
pression. Thus, since resting cells are at an activation level
non-permissive to infection (Pan et al., 2013) but are sufficiently
activated for Tat to function, the putative Tat-activation threshold
is lower than the infection threshold and the two-threshold sce-
nario appears unlikely.
If cellular relaxation does not lead to the establishment of HIV
latency, how is HIV latency established? Previous studies
demonstrated the intrinsic ability of the Tat positive-feedback
circuit to rapidly and stochastically establish latency (Wein-
berger et al., 2005), consistent with recent primate studies
showing that latency is rapidly established within the first
3 days of infection (Whitney et al., 2014) and with cell-culture
models showing latency establishment immediately upon infec-
tion (Calvanese et al., 2013; Dahabieh et al., 2013). Given that
resting CD4+ T lymphocytes are highly resistant to direct HIV
infection (Pan et al., 2013), the rapid establishment of latency
is difficult to reconcile with the cell-state epiphenomenon the-
ory; productively infected cells live <2 days in vivo (Perelson
et al., 1997), while the process of T cell transitioning from active
to memory is a slow and low-probability process (Youngblood
et al., 2013) occurring during and after vigorous expansion of
effector lymphocytes that only begins weeks after infection
(Kuroda et al., 1999). The alternate model examined here (Fig-
ure 3), wherein intrinsic (stochastic) viral circuitry autonomously
regulates HIV latency, also provides a mechanistic basis for
recent observations in patient cells (Ho et al., 2013), showing
that: (1) a significant fraction of latent proviruses are not induced
even if cells are reactivated from a resting-memory state, and
(2) a second identical cellular stimulation (of already activated
cells) induces additional latent proviruses to reactivate. These
results indicate that viral reactivation is probabilistic. While
particularly puzzling for the cellular-control hypothesis, probabi-listic reactivation is consistent with HIV latency being regulated
by an autonomous viral-encoded circuit influenced by stochas-
tic gene-expression fluctuations, which provides rationale for
targeting viral gene-expression circuitry to reactivate latent
HIV (Dar et al., 2014).
To be completely clear, the viral-encoded latency model does
not exclude a role for cellular state in regulating HIV proviral la-
tency. In fact, the Tat-feedback model predicts that latency
establishment is sharply reduced at higher cellular activation
levels (Figure 3C) and that cellular activation probabilistically
reactivates latent virus (Equation 12 in Extended Experimental
Procedures). Experimentally, cellular activation clearly rescues
attenuated feedback (Figure 6B). Similarly, the ability of Tat
expression to reactivate latent virus independent of cellular
activation (Figures 4 and 5) does not imply that in vivo latent re-
activation occurs absent cellular activation. Rather, the results
herein demonstrate—contrary to prevailing dogma—that there
is also an underlying viral program that autonomously regulates
proviral latency.
A viral-encoded latency program naturally raises questions
on the evolutionary origin and function of HIV latency. While
sensor-actuator circuitry would have been consistent with either
the epiphenomenon hypothesis or evolutionary hardwiring, an
autonomous regulatory circuit is invariably hardwired and
must be selectively maintained—especially in a rapidly evolving
virus under strong selection. So, how would latency be benefi-
cial in the natural history of lentiviral infection? In a companion
paper (Rouzine et al., 2015 [this issue of Cell]), we propose
that latency may provide a fitness advantage by acting as a viral
‘‘bet-hedging’’ strategy to enhance net viral transmission prob-
ability. An associated aspect is the decision-making architec-
ture behind latency: Tat positive feedback maintains strong
expression levels robust to cellular perturbations, while large
stochastic fluctuations exhibited by the LTR promoter enable
the system to probabilistically switch (Dar et al., 2012). Notably,
this architecture has been theoretically proposed to be an unre-
liable environmental sensor in fluctuating environments (Brand-
man et al., 2005), suggesting that HIV’s circuit architecture is
precisely the opposite configuration that would be required for
a reliable environmental sensor—a reliable sensor would
respond faithfully to environmental changes—and similar sto-
chastic positive-feedback circuitry has been proposed for
autonomous decision making in other biological systems (Jil-
kine et al., 2011). Overall, viral evolution appears to have
selected for circuitry that both maintains remarkable autonomy
from environmental cues and simultaneously drives probabi-
listic on-off decision making.EXPERIMENTAL PROCEDURES
Primary-Cell Isolation and Cell-Culture Conditions
Primary CD4+ T cells were isolated from peripheral blood obtained from
Stanford Blood Bank (Palo Alto, CA) using RosetteSep Human CD4+
T Cell Enrichment Cocktail from STEMCELL Technologies and Ficoll as
described (Terry et al., 2009). Once isolated, cells were either cultured as
described (Terry et al., 2009) or frozen in 10% DMSO, 90% culture media
at a density of 107 per ml. For infections, primary CD4+ T cells were
pre-activated for 2–3 days with aCD3/CD28 beads (Dynabeads, Life Tech-
nologies) as per manufacturer’s instructions. Cell activation was measuredCell 160, 990–1001, February 26, 2015 ª2015 Elsevier Inc. 999
by flow cytometry with anti-CD25-PE-conjugated antibody and anti-CD69-
APC-conjugated antibody from BD Biosciences. Primary CD4+ T lympho-
cytes, Jurkat T Lymphocytes, and CEMs were all cultured in RPMI 1640
(supplemented with L-glutamine, 10% fetal bovine serum, and 1% peni-
cillin-streptomycin) in a humidified environment at 37C and 5% CO2.
Jurkats and CEM were maintained by passage between 2 3 105 and 2 3
106 cells/ml. Primary cell media was supplemented with 20 U/ml r-IL2
(Peprotech, 200-02).
Computational Modeling
A simplified two-state model of Tat positive feedback was constructed from
experimental data of LTR toggling (Dar et al., 2014; Dar et al., 2012; Singh
et al., 2010; Singh et al., 2012) and simulated using the Gillespie algorithm
(Gillespie, 1977) to test how altering LTR basal transcription rate or Tat pro-
tein stability would affect the activity of the circuit. The chemical reaction
scheme and parameters used are described in Table S1. The outputs from
simulations are the different molecular species in arbitrary numbers. Sto-
chastic simulations were run in Mathematica using the xSSA package
(http://www.wolfram.com/mathematica/ and http://www.xlr8r.info/SSA/).
Initial conditions for all species were set to 0, except for LTRON, which
was set to 1, and simulations were run to time = 200 (arbitrary time units);
500 simulation runs were conducted for each parameter set. See Extended
Experimental Procedures for further details and explanation of simulations
for the more complex model (Figure S2).
Recombinant Virus Production and Infections
Lentivirus was packaged in 293T cells and isolated as described (Dull
et al., 1998; Weinberger et al., 2005). HIV-d2GFP (Jordan et al., 2003)
was packaged with dual-tropic env-encoding plasmid pSVIII-92HT593.1
(NIH AIDS Reagents Program). Before infecting primary cells, activation
beads were removed and cells were mixed with appropriate amount of
virus (to get <10% infection) in 100 ml media and spinoculated at 32C
for 2 hr at 1,000 3 g.
To generate the isoclonal populations with engineered viral circuits, lenti-
virus was added to Jurkat T Lymphocytes at a low MOI to ensure a single
integrated copy of proviral DNA in infected cells. Cells were stimulated
with tumor necrosis factor a (TNFa) and Shield-1 for 18 hr before sorting
for Dendra-expressing cells. Isoclonal and polyclonal populations were
created as described (Weinberger et al., 2005). Sorting and analysis of cells
infected was performed on a FACSAria II. The same procedure was followed
to create the LTR-Tat-Dendra and LTR-mCherry-IRES-Tat-FKBP cell lines.
Inducible Tat cells were generated by transducing Jurkat cells with Tet-
Tat-Dendra and SFFV-rTta lentivirus at high MOI. The cells were incubated
in Dox for 24 hr and then FACS sorted for Dendra+ cells to create a poly-
clonal population. To create the Tet-Tat-Dendra + LTR-mCherry cells, the
polyclonal population was infected with LTR-mCherry lentivirus at a low
MOI. Before sorting for mCherry+ and Dendra+ cells, Dox was added at
500 ng/ml for 24 hr, and single cells were FACS sorted and expanded to
isolate isoclonal populations. The same procedure was followed for the
Tet-Tat-Dendra-FKBP + LTR-mCherry populations; however, 24 hr before
the sort, 1 uM Shield-1 and 500 ng/ml Dox was added to the culture. All
inducible Tat or control HIV infection experiments were performed by incu-
bating 5 3 105 CEM cells in the same titer of inducible Tat or the same titer
of control HIV in the presence or absence of Shield-1 and taking a flow cy-
tometry time point after 48 hr. D-Tat mCherry infections were carried out
using 105–106 inducible Tat (Jurkat) cells in the presence or absence of
500 ng/ml doxycycline.
Flow Cytometry and Analysis
Flow cytometry data were collected on a BD FACSCalibur DxP8, BD LSR II,
or HTFC Intellicyt for stably transduced lines and primary cells and on a
BD FACSAria II for replication-competent virus assays and sorting. All
flow cytometry experiments on replication-competent virus were per-
formed in BSL3 conditions (safety information available upon request).
Flow cytometry data were analyzed in FlowJo and using customized
MATLAB code.1000 Cell 160, 990–1001, February 26, 2015 ª2015 Elsevier Inc.SUPPLEMENTAL INFORMATION
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